MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
Imaging Modalities for Melanoma Screening and Diagnosis
Sponsor: OHSU Knight Cancer Institute
Listed as NCT03699995, this NA trial focuses on Cutaneous Melanoma and Melanocytic Nevus and remains ongoing. Sponsored by OHSU Knight Cancer Institute, it has been updated 16 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
16 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2026 — Feb 2026 [monthly]
Recruiting NA
-
Jul 2025 — Jan 2026 [monthly]
Recruiting NA
-
Feb 2025 — Jul 2025 [monthly]
Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
▶ Show 11 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Sep 2023 — May 2024 [monthly]
Recruiting NA
-
Nov 2022 — Sep 2023 [monthly]
Recruiting NA
-
May 2022 — Nov 2022 [monthly]
Recruiting NA
-
Oct 2021 — May 2022 [monthly]
Recruiting NA
-
Jun 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2020 — Nov 2020 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Nov 2018 — Mar 2020 [monthly]
Active Not Recruiting NA
First recorded
May 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OHSU Knight Cancer Institute
- Oregon Health and Science University
For direct contact, visit the study record on ClinicalTrials.gov .